FDA Approves Second Cubist Antibiotic Of 2014

December 20, 2014 5:30 AM

4 0

Late on a Friday in June, well after 6:00 pm, the FDA approved Cubist Pharmaceuticals’ tedizolid phosphate (Sivextro) for gram-positive skin infections including those caused by MRSA.

This coming Sunday was the PDUFA date for Cubist’s combination drug for gram-negative infections, ceftolozane/tazobactam. but with FDA’s approval of two other drugs today, my wager was that Cubist’s second antibiotic approval of the year would wait until Monday.

Read more

To category page